Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.

Holbrook JT, Sugar EA, Burke AE, Vitale AT, Thorne JE, Davis JL, Jabs DA; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group..

Am J Ophthalmol. 2016 Apr;164:29-36. doi: 10.1016/j.ajo.2015.12.028. Epub 2015 Dec 31.

2.

Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.

Kempen JH, Van Natta ML, Altaweel MM, Dunn JP, Jabs DA, Lightman SL, Thorne JE, Holbrook JT; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group..

Am J Ophthalmol. 2015 Dec;160(6):1133-1141.e9. doi: 10.1016/j.ajo.2015.09.017. Epub 2015 Sep 18.

3.

Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results.

Tomkins-Netzer O, Lightman S, Drye L, Kempen J, Holland GN, Rao NA, Stawell RJ, Vitale A, Jabs DA; Multicenter Uveitis Steroid Treatment Trial Research Group..

Ophthalmology. 2015 Nov;122(11):2351-9. doi: 10.1016/j.ophtha.2015.07.036. Epub 2015 Sep 7.

4.
5.

Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.

Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group., Kempen JH, Altaweel MM, Drye LT, Holbrook JT, Jabs DA, Sugar EA, Thorne JE.

Ophthalmology. 2015 Oct;122(10):1967-75. doi: 10.1016/j.ophtha.2015.06.042. Epub 2015 Aug 20.

6.

Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis.

Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group., Sugar EA, Holbrook JT, Kempen JH, Burke AE, Drye LT, Thorne JE, Louis TA, Jabs DA, Altaweel MM, Frick KD.

Ophthalmology. 2014 Oct;121(10):1855-62. doi: 10.1016/j.ophtha.2014.04.022. Epub 2014 Jun 5.

7.

Authors' response.

Moore DB, Tomkins O, Ben-Zion I.

Surv Ophthalmol. 2013 Sep-Oct;58(5):502. doi: 10.1016/j.survophthal.2013.05.001. No abstract available.

PMID:
23969022
8.

Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema.

Kempen JH, Sugar EA, Jaffe GJ, Acharya NR, Dunn JP, Elner SG, Lightman SL, Thorne JE, Vitale AT, Altaweel MM; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group..

Ophthalmology. 2013 Sep;120(9):1852-9. doi: 10.1016/j.ophtha.2013.01.069. Epub 2013 May 21.

9.

Novel fluorescein angiography-based computer-aided algorithm for assessment of retinal vessel permeability.

Serlin Y, Tal G, Chassidim Y, Parmet Y, Tomkins O, Knyazer B, Friedman A, Levy J.

PLoS One. 2013 Apr 23;8(4):e61599. doi: 10.1371/journal.pone.0061599. Print 2013.

10.

A review of primary congenital glaucoma in the developing world.

Moore DB, Tomkins O, Ben-Zion I.

Surv Ophthalmol. 2013 May-Jun;58(3):278-85. doi: 10.1016/j.survophthal.2012.11.003. Epub 2013 Mar 5. Review.

PMID:
23465868
11.

Evaluation of intraocular pressure according to corneal thickness before and after excimer laser corneal ablation for myopia.

Hamed-Azzam S, Briscoe D, Tomkins O, Shehedeh-Mashor R, Garzozi H.

Int Ophthalmol. 2013 Aug;33(4):349-54. doi: 10.1007/s10792-012-9701-7. Epub 2012 Dec 29.

PMID:
23275189
12.

Outcomes of pediatric cataract surgery at a tertiary care center in rural southern Ethiopia.

Tomkins O, Ben-Zion I, Moore DB, Helveston EE.

Arch Ophthalmol. 2011 Oct;129(10):1293-7. doi: 10.1001/archophthalmol.2011.268.

PMID:
21987671
13.

Congenital unilateral brown syndrome in non-twin siblings.

Tomkins O, Abel-Peleg B, Ben-Zion I.

J Pediatr Ophthalmol Strabismus. 2011 Jul-Aug;48(4):253-4. doi: 10.3928/01913913-20110506-01. No abstract available.

PMID:
21766745
14.

Management of recurrent pterygium with intraoperative mitomycin C and conjunctival autograft with fibrin glue.

Shehadeh-Mashor R, Srinivasan S, Boimer C, Lee K, Tomkins O, Slomovic AR.

Am J Ophthalmol. 2011 Nov;152(5):730-2. doi: 10.1016/j.ajo.2011.04.034. Epub 2011 Jul 13.

PMID:
21742307
15.

The postoperative occurrence of cardio-respiratory adverse events in small infants undergoing gastrointestinal surgery: a prospective comparison of general anesthesia and combined spinal-epidural anesthesia.

Somri M, Coran AG, Mattar I, Teszler C, Shaoul R, Tomkins O, Tome R, Mogilner JG, Sukhotnik I, Gaitini L.

Pediatr Surg Int. 2011 Nov;27(11):1173-8. doi: 10.1007/s00383-011-2939-8. Epub 2011 Jun 21.

PMID:
21691762
16.

Blood-brain barrier breakdown following traumatic brain injury: a possible role in posttraumatic epilepsy.

Tomkins O, Feintuch A, Benifla M, Cohen A, Friedman A, Shelef I.

Cardiovasc Psychiatry Neurol. 2011;2011:765923. doi: 10.1155/2011/765923. Epub 2011 Feb 22.

17.

Surgical results in the management of advanced primary congenital glaucoma in a rural pediatric population.

Ben-Zion I, Tomkins O, Moore DB, Helveston EM.

Ophthalmology. 2011 Feb;118(2):231-5.e1. doi: 10.1016/j.ophtha.2010.02.027. Epub 2010 Jun 25.

PMID:
20579739
18.

Fusarium keratitis acquired during travel to Namibia.

Zaigraykina N, Tomkins O, Garzozi HJ, Potasman I.

J Travel Med. 2010 May-Jun;17(3):209-11. doi: 10.1111/j.1708-8305.2010.00408.x.

19.

Clinical assessment of thyroid related orbitopathy: a review.

Vardizer Y, Tomkins O, Briscoe D.

Pediatr Endocrinol Rev. 2010 Mar;7 Suppl 2:186-92. Review.

PMID:
20467361
20.

Treatment of dry eye syndrome with orally administered CF101: data from a phase 2 clinical trial.

Avni I, Garzozi HJ, Barequet IS, Segev F, Varssano D, Sartani G, Chetrit N, Bakshi E, Zadok D, Tomkins O, Litvin G, Jacobson KA, Fishman S, Harpaz Z, Farbstein M, Yehuda SB, Silverman MH, Kerns WD, Bristol DR, Cohn I, Fishman P.

Ophthalmology. 2010 Jul;117(7):1287-93. doi: 10.1016/j.ophtha.2009.11.029. Epub 2010 Mar 20.

Supplemental Content

Loading ...
Support Center